Medical Marijuana EBIT

Medical Marijuana (MJNA) currently reports a EBIT of $-1.6M as of March 2026. That compares with $640K in the prior-year period — down 349.6% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Medical Marijuana's EBIT history and peer comparisons.

Medical Marijuana's EBIT decreased from $640K to $-1.6M — a 349.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medical Marijuana's EBIT of $-1.6M is lower than the Healthcare sector average of $23B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Medical Marijuana reported $-1.6M in EBIT as of March 2026. That compares with $640K in the prior-year period — down 349.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-1.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Medical Marijuana, and consider following MJNA for alerts when major investors trade the stock.